Inactive conformation of an insulin despite its wild-type sequence

Protein Science

Volumn 6, Issue 3, 1997, Pages 580-587

  Kurapkat, Günther ^a   De Wolf, Elke ^a   Grötzinger, Joachim ^a   Wollmer, Axel ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

conformation; insulin; NMR spectroscopy; structure

Indexed keywords

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CARBOXY TERMINAL SEQUENCE; HYDROPHOBICITY; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN CONFORMATION; STRUCTURE ACTIVITY RELATION;

EID: 0030941110     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1002/pro.5560060307     Document Type: Article

References (53)

1. Baker EN, Blundell TL, Cutfield JF, Cutfield SM, Dodson EJ, Dodson GG, Hodgkin DM, Hubbard RE, Isaacs NW, Reynolds CD, Sakabe K, Sakabe N, Vijayan NM. 1988. The structure of 2Zn pig insulin crystals at 1.5 Å resolution. Philos Trans R Soc Lond B Biol Sci 319:369-456.
2. Berendsen H, Postma J, van Gunsteren W, DiNola A, Haak J. 1984. Molecular dynamics with coupling to an external bath. J Chem Phys 81:3684-3690.
3. Bi R, Dauter Z, Dodson E, Dodson G, Giordano F, Reynolds C. 1984. Insulin's structure as a modified and monomeric monomer. Biopolymers 23:391-395.
4. Brandenburg D. 1972. Preparation of N A1, N B29-adipoylinsulin, an intramolecularly crosslinked derivative of beef insulin. Hoppe Seylers Z Physiol Chem 353:869-873.
5. Brandenburg D, Busse WD, Gattner HG, Zahn H, Wollmer A, Gliemann J, Puls W. 1973a. Structure function studies with chemically modified insulins. In: Jakubke HD, Hanson HE, eds. Peptides 1972. Amsterdam, The Netherlands: Elsevier. pp 270-283.
6. Brandenburg D, Schermutzki W, Zahn H. 1973b. NalphaA1-N-epsilon B-29-crosslinked diaminosuberoylinsulin, a potential intermediate for the chemical synthesis of insulin. Hoppe Seylers Z Physiol Chem 354:1521-1524.
7. Brandenburg D, Wollmer A. 1973. The effect of a non-peptide interchain crosslink on the reoxidation of reduced insulin. Hoppe Seylers Z Physiol Chem 354:613-627.
8. Brems D, Brown P, Nakagawa S, Tager H. 1991. The conformational stability and flexibility of insulin with an additional intramolecular cross-link. J Biol Chem 266:1611-1615.
9. Casaretto M, Spoden M, Diaconescu C, Gattner HG, Zahn H, Brandenburg D, Wollmer A. 1987. Shortened insulin with enhanced in vitro potency. Biol Chem Hoppe Seyler 368:709-716.
10. Cosmatos A, Ferderigos N, Katsoyannis PG. 1979. Chemical synthesis of [des (tetrapeptide B27-30), Tyr(NH2)26-B] and [des(pentapeptide B26-30), Phe(NH2)25-B] bovine insulins. Int J Pept Protein Res 14:457-71.
11. Crippen GM, Havel TF. 1978. Stable calculation of coordinates from distance information. Acta Crystallogr A 34:282-284.
12. Cutfield JF, Cutfield SM, Dodson EJ, Dodson GG, Hodgkin DC, Reynolds CD. 1981. Evidence concerning insulin activity from the structure of a cross-linked derivative. Hoppe Seylers Z Physiol Chem 362:755-761.
13. Dai J, Lou M, You Y, Liang D. 1987. Refinement of the structure of despent-peptide (B26-30) insulin at 1.5 Å resolution. Sci Sin B30:55-65.
14. Delsuc MA. 1988. A new maximum entropy processing algorithm, with applications to nuclear magnetic resonance experiments. In: Skilling J, ed. Maximum entropy and Bayesian methods. Cambridge, England/Amsterdam, The Netherlands: Kluwer Academic.
15. Derewenda U, Derewenda ZS, Dodson EJ, Dodson GG, Bing X, Markussen J. 1991. X-ray analysis of the single chain B29-A1 peptide-linked insulin molecule. A completely inactive analogue. J Mol Biol 220:425-433.
16. Dodson G, Cutfield S, Hoenjet E, Wollmer A, Branderburg D. 1980. Crystal structure, aggregation and biological potency of beef insulin cross-linked at A1 and B29 by diaminosuberic acid. In: Brandenburg D, Wollmer A, eds. Structure and function of insulin and related hormones. Berlin/New York: pp 17-26.
17. Fischer WH, Saunders D, Brandenburg D, Wollmer A, Zahn H. 1985. A shortened insulin with full in vitro potency. Biol Chem Hoppe Seyler 366:521-525.
18. Freychet P, Brandenberg D, Wollmer A. 1974. Receptor-binding assay of chemically modified insulins. Comparison with in vitro and in vivo bioassays. Diabetologia 10:1-5.
19. Gatter HG. 1975. B-chain shortening of matrix-bound insulin by pepsin, I: Preparation and properties of bovine des-pentapeptide(B26-30) insulin. Hoppe Seylers Z Physiol Chem 356:1397-1404.
20. Gliemann J, Gammeltoft S. 1974. The biological activity and the binding affinity of modified insulins determined on isolated rat fat cells. Diabetologia 10:105-113.
21. Havel TF, Kuntz ID, Crippen GM. 1983. The theory and practice of distance geometry. Bull Math Biol 45:665-720.
22. Hua QX, Shoelson SE, Inouye K, Weiss MA. 1993. Paradoxical structure and function in a mutant human insulin associated with diabetes mellitus. Proc Natl Acad Sci USA 90:582-586.
23. Hua QX, Shoelson SE, Kochoyan M, Weiss MA. 1991. Receptor binding redefined by a structural switch in a mutant human insulin. Nature 354:238-241.
24. Hua QX, Shoelson SE, Weiss MA. 1992. Nonlocal structural perturbations in a mutant human insulin: Sequential resonance assignment and 13C-isotope-aided 2D-NMR studies of [Phe B24 → Gly]insulin with implications for receptor recognition. Biochemistry 31:11940-11951.
25. Hua QX, Weiss MA. 1990. Toward the solution structure of human insulin: Sequential 2D 1H NMR assignment of a des-pentapeptide analogue and comparison with crystal structure. Biochemistry 29:10545-10555.
26. Hua QX, Weiss MA. 1991. Comparative 2D NMR studies of human insulin and des-pentapeptide insulin: Sequential resonance assignment and implications for protein dynamics and receptor recognition. Biochemistry 30:5505-5515.
27. Johnson BA, Blevins RA. 1994. NMR view: A computer program for the visualization and analysis of NMR data. J Biomol NMR 4:603-614.
28. Jones RH, Dron DI, Ellis MJ, Sönksen PH, Brandenburg D. 1976. Biological properties of chemically modified insulins. I. Biological activity of proinsulin and insulin modified at A1-glycine and B29-lysine. Diabetologia 12:601-608.
29. Kaptein R, Boelens R, Scheek RM, van Gunsteren WF. 1988. Protein structures from NMR. Biochemistry 27:5389-5395.
30. Kobayashi M, Sasaoka T, Sugibayashi M, Iwanishi M, Shigeta Y. 1989. Receptor binding and biologic activity of biosynthetic human insulin and mini-proinsulin produced by recombinant gene technology. Diabetes Res Clin Pract 7:25-28.
31. Krüger P, Hahnen J, Wollmer A. 1994. Comparative studies on the dynamics of crosslinked insulin. Eur Biophys J 23:177-187.
32. Kurose T, Pashmforoush M, Yoshimasa Y, Carroll R, Schwartz GP, Burke GT, Katsoyannis PG, Steiner DF. 1994. Cross-linking of a B25 azidophenylalanine insulin drivative to the carboxyl-terminal region of the alpha-subunit of the insulin receptor. Identification of a new insulin-binding domain in the insulin receptor. J Biol Chem 269:29190-29197.
33. Leyer S, Gattner HG, Leithäuser M, Brandenburg D, Wollner A, Höker H. 1995. The role of the C-terminus of the insulin B-chain in modulating structural and functional properties of the hormone. Int J Pept Protein Res 46:397-407.
34. Lindsay D. 1971. Intramolecular cross-linked insulin. FEBS Lett 21:105-108.
35. Ludvigsen S, Roy M, Thorgesen H, Kaarsholm NC. 1994. High-resolution structure of an engineered biologically potent insulin monomer, B16Tyr → His, as determined by nuclear magnetic resonance spectroscopy. Biochemistry 33:7998-8006.
36. Markussen J, Jorgensen KH, Sorensen AR, Thim L. 1985. Single chain des(B30) insulin. Intramolecular crosslinking of insulin by trypsin catalyzed transpeptidation. Int J Pept Protein Res 26:70-77.
37. Mirmira RG, Nakagawa SH, Tager HS. 1991. Importance of the character and configuration of residues B24, B25, and B26 in insulin-receptor interactions. J Biol Chem 266:1428-1436.
38. Mirmira RG, Tager HS. 1989. Role of the phenylalanine B24 side chain in directing insulin interaction with its receptor. Importance of main chain conformation. J Biol Chem 264:6349-6354. [published erratum appears in J Biol Chem 264(29):17613; Oct 15, 1989]
39. Murray-Rust J, McLeod AN, Blundell TL, Wood SP. 1992. Structure and evolution of insulins: Implications for receptor binding. Bioessays 14:325-331.
40. Nakagawa SH, Johansen NL, Madsen K, Schwartz TW, Tager HS. 1993. Implications of replacing peptide bons in the COOH-terminal B chain domain of insulin by the psi (CH2-NH) linker. Int J Pept Protein Res 42:578-584.
41. Nakagawa SH, Tager HS. 1986. Role of the phenylalanine B25 side chain in directing insulin interaction with its receptor. Steric and conformational effects. J Biol Chem 261:7332-7341.
42. Nakagawa SH, Tager HS. 1987. Role of the COOH-terminal B-chain domain in insulin-receptor interactions. Identification of perturbations involving the insulin mainchain. J Biol Chem 262:12054-12058.
43. Nakagawa SH, Tager HS. 1989. Perturbation of insulin-receptor interactions by intramoloecular harmone cross-linking. Analysis of relative movement among residues A1, B1, and B29. J Biol Chem 264:272-279.
44. Nakagawa SH, Tager HS. 1992. Importance of aliphatic side-chain structure at positions 2 and 3 of the insulin A chain in insulin-receptor interactions. Biochemistry 31:3204-3214.
45. Pullen RA, Lindsay DG, Wood SP, Tickle IJ, Blundell TL, Wollmer A, Krail G, Brandenburg D, Zahn H, Gliemann J, Gammeltoft S. 1979. Receptor-binding region of insulin. Nature 259-369-373.
46. Scheek RM, van Gunsteren W, Kaptein R. 1989. Molecular dynamics simulation techniques for determination of molecular structures from nuclear magnetic resonance data. Methods Enzymol 177:204-218.
47. Srinivasa BR, Carpenter FH. 1983. Intramolecular cross-linking of insulin. Preparation and properties of oxalyl-and malonyl-bis(methionyl) insulin. Int J Pept Protein Res 22:214-222.
48. Wishart DS, Sykes BD, Richards FM. 1992. The chemical shift index: A fast and simple method for the assignment of protein secondary structure through NMR spectroscopy. Biochemistry 31:1647-1651.
49. Wollmer A, Brandenburg D, Vogt HP, Schermutzki W. 1974. Reduction/ reoxidation studies with cross-linked insulin derivatives. Hoppe Seylers Z Physiol Chem 355:1471-1476.
50. Wollmer A, Gilge G, Brandenburg D, Gattner HG. 1994. An insulin with the native sequence but virtually no activity. Biol Chem Hoppe Seyler 375:219-222.
51. Wollmer A, Hahnen J, Krüger P, Grötzinger J. 1989. Structure, function and dynamics of A1-B29 crosslinked insulin. Bull Int Diabetes Fed 34:59-61.
52. Wood SP, Blundell TL, Wollmer A, Lazarus NR, Neville RW3. 1975. The relation of conformation and association of insulin to receptor binding; X-ray and circular-dichroism studies on bovine and hystricomorph insulins. Eur J Biochem 55:531-542.
53. Wüthrich K. 1986. Nuclear Overhauser Enhancement (NOE) in biopolymers. In: Wüthrich K, eds. NMR of proteins and nucleic acids. New York: John Wiley & Sons. pp 93-113.